Cover Image

Therapy Related Chronic Myeloid Leukemia (trCML) or non-Therapy Related Second Malignancy Chronic Myeloid Leukemia (smCML) following Diffuse Large B-Cell Lymphoma(DLBCL): A Case Report and Review of Literature

Robert Louis, Sunil Kumar Gupta, Sonal Jain, Anurag Mehta, Mohit Agarwal

Abstract


 

 

Introduction: Second malignancy could be either previous therapy related or non-therapy related like syndromic or shared etiologic exposure. It could be either a hematological/solid malignancy following tretment for previous solid tumour or prior hematological malignanacy.Review of literature regarding secondary Chronic Myeloid Leukemia (CML) following previous active treatment for primary cancer is listed out for further understanding.

Presentation of Case: We describe a 71 year old elderly male who developed Chronic Myeloid Leukemia(CML) after a period of 6 years during follow up of Stage IV Diffuse Large B-Cell Lymphoma(DLBCL) for which he received 8 cycles of R-CHOP based Chemo-immunotherapy in 2008 .Whether it is therapy related Chronic Myeloid Leukemia (trCML) following prior cytotoxic treatment or simply a non-therapy related second malignancy hronic Myeloid Leukemia(smCML) is a matter of debate.However our patient responded dramatically like denova CML to imatinib therapy.

Conclusion: Therapy related CML or non therapy related second malignancy CML following DLBCL treatment is rare but responds dramatically like denova CML to imatinib therapy.

 

 

 

 

 

 


Keywords


Therapy-related CML; Second malignancy CML; CML following DLBCL treatment

Full Text:

PDF

References


Boice JD, Jr, Storm HH, Curtis RE, Jensen OM, Kleinerman RA, Jensen HS. et al., Introduction to the study of multiple primary cancers National Cancer Institute Monograph No 68 – Multiple Primary Cancers in Connecticut and Denmark 1985NIH Publication: Bethesda; 3-9.9 NCI (ed) pp

Travis LB, Curtis RE, Boice JD Jr,Hankey BF, Fraumeni JF Jr. Second cancers following non-Hodgkin's lymphoma. Cancer. 1991, 67(7):2002-2009

Tward JD, Wendland MM, Shrieve DC, Szabo A, Gaffney DK.The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Cancer. 2006, 107(1):108-115

Brennan P, Scélo G, Hemminki K, Mellemkjaer L, Tracey E, Andersen A et al. Second primary cancers among 109 000 cases of non-Hodgkin’s lymphoma. British Journal of Cancer. 2005 93(1), 159-166

Bari A, Marcheselli L, Marcheselli R, Liardo EV, Pozzi S, Ferri P et al. Therapy-Related Myeloid Neoplasm in Non-Hodgkin Lymphoma Survivors. Mediterranean Journal of Hematology and Infectious Diseases. 2011, 3(1): e2011065

Pirani M, Marcheselli R, Marcheselli L, Bari A, Federico M, Sacchi S. Risk for second malignancies in non-Hodgkin's lymphoma survivors: a meta-analysis. Ann Oncol. 2011, 22(8):1845-1858

Hemminki K,Lenner P,Sundquist J,Bermejo JL.Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis. J Clin Oncol. 2008, 26(11):1850-1857

Lorenzo Bermejo J,Pukkala E,Johannesen TB,Sundquist J,Hemminki K.Age-time risk patterns of solid cancers in 60901 non-Hodgkin lymphoma survivors from Finland, Norway and Sweden. Br J Haematol. 164(5):675-683

Lindsay M, Morton,Rochelle E, Curtis,Martha S, Linet et al. Second Malignancy Risks After Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia: Differences by Lymphoma Subtype. J Clin Oncol. 2010, 28(33): 4935-4944

Demiriz IŞ, Tekgündüz E, Bozdağ SC, Altuntaş F. Chronic myeloid leukemia as a secondary malignancy following treatment of diffuse large B-cell lymphoma. Turk J Haematol. 2014, 31(1):92-84

Shibazaki M, Sumi M, Takeda W, Kirihara T, Kurihara T, Sato K et al. Therapy-related chronic myelogenous leukemia following RFM therapy in a patient with follicular lymphoma. Rinsho Ketsueki. 2014, 55(8):970-974

Lee HY, Lee KH, Hyun MS, Kim MK, Koh SA, Cho HS. Chronic myeloid leukemia as a secondary malignancy after diffuse large B-cell lymphoma. Korean J Intern Med. 2014, 29(2):250-252

Aguiar RC. Therapy-related chronic myeloid leukemia: an epidemiological, clinical and pathogenetic appraisal. Leuk Lymphoma. 1998, 29(1-2):17-26

Specchia G, Buquicchio C, Albano F, Liso A, Pannunzio A, Mestice A et al.Non-treatment-related chronic myeloid leukemia as a second malignancy. Leuk Res. 2004, 28(2):115-119

Zahra K, Ben Fredj W, Ben Youssef Y, Zaghouani H, Chebchoub I, Zaier M et al. Chronic myeloid leukemia as a secondary malignancy after lymphoma in a child. A case report and review of the literature. Onkologie. 2012, 35(11):690-693

Alsop S, Sanger WG, Elenitoba-Johnson KS, Lim MS. Chronic myeloid leukemia as a secondary malignancy after ALK-positive anaplastic large cell lymphoma. Hum Pathol. 2007, 38(10):1576-1580

Bolaños-Meade J, Sarkodee-Adoo C, Khanwani SL. CML after treatment for lymphoid malignancy:Therapy-related CML or coincidence? Am J Hematol. 2002, 71(2):139

Breccia M, Martelli M, Cannella L, Russo E, Finolezzi E, Stefanizzi C et al. Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphoma. Leuk Res. 2008, 32(2):353-355

Hsiao HH, Liu TC, Chang CS, Sue YC, Chen TP, Lin SF. Secondary chronic myelogenous leukemia after autologous peripheral blood stem cell transplantation for lymphoma. Int J Hematol. 2001, 73(1):126-128

Wandroo FA, Bareford D, el-Jehani F. Chronic myeloid leukaemia occurring in a patient with hairy cell leukaemia. J Clin Pathol. 2000, 53(12):940-941

Ramanarayanan J, Dunford LM, Baer MR, Sait SN, Lawrence W, McCarthy PL. Chronic myeloid leukemia after treatment of lymphoid malignancies: response to imatinib mesylate and favorable outcomes in three patients. Leuk Res. 2006, 30(6):701-705

Waldman D, Weintraub M, Freeman A, Neumann Y, Rechavi G, Toren A. Favorable early response of secondary chronic myeloid leukemia to imatinib. Am J Hematol. 2004, 75(4):217-219

Verhoef GE, Demuynck H, Stul MS, Cassiman JJ, Mecucci C, Van Den Berghe H et al. Philadelphia chromosome-positive chronic myelogenous leukemia in treated Hodgkin's disease. Cancer Genet Cytogenet. 1990, 49(2):171-176

Cazzola M, Bergamaschi G, Melazzini M, Ponchio L, Rosti V, Molinari E. Chronic myelogenous leukemia following radiotherapy and chemotherapy for non-Hodgkin lymphoma. Haematologica. 1990, 75(5):477-479

Ragupathi L, Najfeld V, Chari A, Petersen B, Jagannath S, Mascarenhas J. A case report of chronic myelogenous leukemia in a patient with multiple myeloma and a review of the literature. Clin Lymphoma Myeloma Leuk. 2013, 13(2):175-179

Majado MJ, González García C, Marín-Blazquez MD, Morales Lázaro A, Moreno Moreno M.Appearance of a chronic myeloid leukemia in Waldenström's macroglobulinemia. Sangre (Barc). 1992, 37(6):465-466

Gokel Y, Paydas S. Chronic myeloid leukemia in a patient with colon adenocarcinoma. Haematologia (Budap). 2002, 32(4):501-503

Vakili-Sadeghi M, Omranpour M. Chronic myeloid leukemia following colon cancer treatment: A case report and literature review. Caspian J Intern Med. 2013, 4(3):739-742

Kadikoylu G, Yavasoglu I, Barutca S, Meydan N, Bolaman Z. Chronic myeloid leukemia following the treatment of rectal adenocarcinoma. Med Oncol. 2008, 25(4):467-470

Buxhofer-Ausch V, Hinterberger-Fischer M, Hinterberger W. Bcr-abl positive blast crisis of chronic myeloid leukemia emerging in a case of metastatic colorectal cancer 3 months after completion of an 8-month course of cetuximab and irinotecan. Eur J Haematol. 2006, 76(5):447-448

Manabe M, Nishii T, Okita J, Nagasaki J, Harada N, Aoyama Y, Kumura T, Ohta T, Furukawa Y, Takeuchi K, Mugitani A. Chronic myelogenous leukemia after postoperative adjuvant S-1 therapy for rectal cancer: a case report. Am J Blood Res. 2013, 3(4):286-289

Pavithran K, Doval DC.Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine. Am J Clin Oncol. 2005, 28(2):216

Wang KL, Lin LY, Chen PM, Lin HD. Chronic myeloid leukemia after treatment with 131 for thyroid carcinoma. J Chin Med Assoc. 2005, 68(5):230-233

Walgraeve D, Verhoef G, Stul M, Cassiman JJ, Mecucci C, Van den Berghe H et al. Chronic myelogenous leukemia after treatment with 131I for thyroid carcinoma. Report of a case and review of the literature. Cancer Genet Cytogenet. 1991, 55(2):217-224

Shimon I, Kneller A, Olchovsky D. Chronic myeloid leukaemia following 131I treatment for thyroid carcinoma: a report of two cases and review of the literature. Clin Endocrinol (Oxf). 1995, 43(5):651-654

Porta C, Casagranda I, Semino G, Moroni M, Ratto C. Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient. Haematologica. 1993, 78(1):56-57

Bauduer F, Ducout L, Dastugue N, Marolleau JP. Chronic myeloid leukemia as a secondary neoplasm after anti-cancer radiotherapy: a report of three cases and a brief review of the literature. Leuk Lymphoma. 2002, 43(5):1057-1060

Abu-Ghanem S, Rabinovich A, Delgado B, Benharroch D, Ariad S, Levi I.et al.,Chronic myelogenous leukemia diagnosed in two patients with breast cancer. Leuk Lymphoma. 2011, 52(12):2399-2401

Tsuzuki M, Handa K, Yamamoto K, Hasegawa A, Yamamoto Y, Watanabe M.et al.,Chronic myeloid leukemia following chemotherapy with 5'-deoxy-5-fluorouridine for gastric cancer. Intern Med. 2008, 47(19):1739-1741

Higuchi M, Nishinaka H, Yamano Y. A case of chronic myeloid leukemia following TS-1 therapy for advanced gastric cancer. Gan To Kagaku Ryoho. 2006, 33(13):2049-2052

Waller CF, Fetscher S, Lange W. Secondary chronic myelogenous leukemia after chemotherapy followed by adjuvant radiotherapy for small cell lung cancer. Leuk Res. 1999, 23(10):961-964

Noda M, Shoda T, Takimoto Y, Okita H. Chronic myelogenous leukemia following therapy for pineal germinoma. Rinsho Ketsueki. 2004, 45(1):72-74

Numata A, Shimoda K, Gondo H, Kato K, Aoki K, Ito Y et al. Therapy-related chronic myelogenous leukaemia following autologous stem cell transplantation for Ewing's sarcoma. Br J Haematol. 2002, 117(3):613-616

Langabeer SE, Burke A, McCarron SL, Kelly J, Carroll P, Browne PV, Conneally E. Chronic myeloid leukaemia presenting post-radiotherapy for prostate cancer: further evidence for an immunosurveillance effect. Br J Haematol. 2013, 162(5):708-710

Sakamoto E, Sawada T, Osugi H, Nakamae H, Koh KR, Yamane T et al. Chronic myeloid leukemia in two patients with gastrointestinal stromal tumor. Int J Hematol. 2008, 88(3):348-350


Refbacks

  • There are currently no refbacks.


AJCC-REP (ISSN 2572-5742)Copyright © 2012-2020. All rights reserved. Published by Ivy Union Publishing, 3204 Valley Rush Dr, Apex, North Carolina 27502, United States